Integrated chemical and genetic screens unveil FSP1 mechanisms of ferroptosis regulation
© 2023. The Author(s)..
Ferroptosis, marked by iron-dependent lipid peroxidation, may present an Achilles heel for the treatment of cancers. Ferroptosis suppressor protein-1 (FSP1), as the second ferroptosis mainstay, efficiently prevents lipid peroxidation via NAD(P)H-dependent reduction of quinones. Because its molecular mechanisms have remained obscure, we studied numerous FSP1 mutations present in cancer or identified by untargeted random mutagenesis. This mutational analysis elucidates the FAD/NAD(P)H-binding site and proton-transfer function of FSP1, which emerged to be evolutionarily conserved among different NADH quinone reductases. Using random mutagenesis screens, we uncover the mechanism of action of next-generation FSP1 inhibitors. Our studies identify the binding pocket of the first FSP1 inhibitor, iFSP1, and introduce the first species-independent FSP1 inhibitor, targeting the NAD(P)H-binding pocket. Conclusively, our study provides new insights into the molecular functions of FSP1 and enables the rational design of FSP1 inhibitors targeting cancer cells.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:30 |
|---|---|
| Enthalten in: |
Nature structural & molecular biology - 30(2023), 11 vom: 13. Nov., Seite 1806-1815 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Nakamura, Toshitaka [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 15.11.2023 Date Revised 15.12.2023 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1038/s41594-023-01136-y |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM364489464 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM364489464 | ||
| 003 | DE-627 | ||
| 005 | 20231227132644.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1038/s41594-023-01136-y |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1229.xml |
| 035 | |a (DE-627)NLM364489464 | ||
| 035 | |a (NLM)37957306 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Nakamura, Toshitaka |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Integrated chemical and genetic screens unveil FSP1 mechanisms of ferroptosis regulation |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 15.11.2023 | ||
| 500 | |a Date Revised 15.12.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2023. The Author(s). | ||
| 520 | |a Ferroptosis, marked by iron-dependent lipid peroxidation, may present an Achilles heel for the treatment of cancers. Ferroptosis suppressor protein-1 (FSP1), as the second ferroptosis mainstay, efficiently prevents lipid peroxidation via NAD(P)H-dependent reduction of quinones. Because its molecular mechanisms have remained obscure, we studied numerous FSP1 mutations present in cancer or identified by untargeted random mutagenesis. This mutational analysis elucidates the FAD/NAD(P)H-binding site and proton-transfer function of FSP1, which emerged to be evolutionarily conserved among different NADH quinone reductases. Using random mutagenesis screens, we uncover the mechanism of action of next-generation FSP1 inhibitors. Our studies identify the binding pocket of the first FSP1 inhibitor, iFSP1, and introduce the first species-independent FSP1 inhibitor, targeting the NAD(P)H-binding pocket. Conclusively, our study provides new insights into the molecular functions of FSP1 and enables the rational design of FSP1 inhibitors targeting cancer cells | ||
| 650 | 4 | |a Journal Article | |
| 650 | 7 | |a NAD |2 NLM | |
| 650 | 7 | |a 0U46U6E8UK |2 NLM | |
| 650 | 7 | |a Protons |2 NLM | |
| 700 | 1 | |a Mishima, Eikan |e verfasserin |4 aut | |
| 700 | 1 | |a Yamada, Naoya |e verfasserin |4 aut | |
| 700 | 1 | |a Mourão, André Santos Dias |e verfasserin |4 aut | |
| 700 | 1 | |a Trümbach, Dietrich |e verfasserin |4 aut | |
| 700 | 1 | |a Doll, Sebastian |e verfasserin |4 aut | |
| 700 | 1 | |a Wanninger, Jonas |e verfasserin |4 aut | |
| 700 | 1 | |a Lytton, Elena |e verfasserin |4 aut | |
| 700 | 1 | |a Sennhenn, Peter |e verfasserin |4 aut | |
| 700 | 1 | |a Nishida Xavier da Silva, Thamara |e verfasserin |4 aut | |
| 700 | 1 | |a Angeli, José Pedro Friedmann |e verfasserin |4 aut | |
| 700 | 1 | |a Sattler, Michael |e verfasserin |4 aut | |
| 700 | 1 | |a Proneth, Bettina |e verfasserin |4 aut | |
| 700 | 1 | |a Conrad, Marcus |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Nature structural & molecular biology |d 2004 |g 30(2023), 11 vom: 13. Nov., Seite 1806-1815 |w (DE-627)NLM144280140 |x 1545-9985 |7 nnns |
| 773 | 1 | 8 | |g volume:30 |g year:2023 |g number:11 |g day:13 |g month:11 |g pages:1806-1815 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1038/s41594-023-01136-y |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 30 |j 2023 |e 11 |b 13 |c 11 |h 1806-1815 | ||